Indo US Bio-Tech Ltd. (IN:INDOUS)
:INDOUS
Want to see IN:INDOUS full AI Analyst Report?
Total Valuation
Indo US Bio-Tech Ltd. has a market cap or net worth of ₹2.03B. The enterprise value is ₹2.31B.
Market Cap₹2.03B
Enterprise Value₹2.31B
Share Statistics
Indo US Bio-Tech Ltd. has 20,052,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,052,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Indo US Bio-Tech Ltd.’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 0.23%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)0.23%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee1.18M
Profits Per Employee187.21K
Employee Count883
Asset Turnover1.06
Inventory Turnover1.05
Valuation Ratios
The current PE Ratio of Indo US Bio-Tech Ltd. is 20.5. Indo US Bio-Tech Ltd.’s PEG ratio is 0.00.
PE Ratio20.5
PS Ratio3.01
PB Ratio3.98
Price to Fair Value3.98
Price to FCF-31.05K
Price to Operating Cash Flow-27.49
PEG Ratio0.00
Income Statement
In the last 12 months, Indo US Bio-Tech Ltd. had revenue of 1.04B and earned 162.67M in profits. Earnings per share was 0.09.
Revenue1.04B
Gross Profit294.70M
Operating Income2.11M
Pretax Income165.31M
Net Income162.67M
EBITDA2.23M
Earnings Per Share (EPS)0.09
Cash Flow
In the last 12 months, operating cash flow was -74.56M and capital expenditures -8.79M, giving a free cash flow of -83.36M billion.
Operating Cash Flow-74.56M
Free Cash Flow-83.36M
Free Cash Flow per Share-4.16
Dividends & Yields
Indo US Bio-Tech Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.87
52-Week Price Change-33.01%
50-Day Moving Average105.26
200-Day Moving Average128.43
Relative Strength Index (RSI)41.30
Average Volume (3m)983.00
Important Dates
Indo US Bio-Tech Ltd. upcoming earnings date is Jun 1, 2026, TBA (Not Confirmed).
Last Earnings DateJan 21, 2026
Next Earnings DateJun 1, 2026
Ex-Dividend Date―
Financial Position
Indo US Bio-Tech Ltd. as a current ratio of 5.31, with Debt / Equity ratio of 31.90%
Current Ratio5.31
Quick Ratio0.98
Debt to Market Cap0.05
Net Debt to EBITDA65.28
Interest Coverage Ratio0.15
Taxes
In the past 12 months, Indo US Bio-Tech Ltd. has paid 30.76K in taxes.
Income Tax30.76K
Effective Tax Rate<0.01
Enterprise Valuation
Indo US Bio-Tech Ltd. EV to EBITDA ratio is 1.46K, with an EV/FCF ratio of -32.49K.
EV to Sales3.15
EV to EBITDA1.46K
EV to Free Cash Flow-32.49K
EV to Operating Cash Flow35.87M
Balance Sheet
Indo US Bio-Tech Ltd. has ₹5.88M in cash and marketable securities with ₹276.43M in debt, giving a net cash position of -₹270.56M billion.
Cash & Marketable Securities₹5.88M
Total Debt₹276.43M
Net Cash-₹270.56M
Net Cash Per Share-₹13.49
Tangible Book Value Per Share₹39.16
Margins
Gross margin is 25.32%, with operating margin of 0.20%, and net profit margin of 15.67%.
Gross Margin25.32%
Operating Margin0.20%
Pretax Margin15.92%
Net Profit Margin15.67%
EBITDA Margin0.22%
EBIT Margin0.20%
Analyst Forecast
The average price target for Indo US Bio-Tech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast36.63%
EPS Growth Forecast13.19%